For head and neck cancer patients in Taiwan’s Yunlin and Chiayi regions, a new hope emerged on April 27, 2026, as Boron Neutron Capture Therapy (BNCT) took center stage at a specialized educational event hosted by Dalin Tzu Chi Hospital. The session, part of a nationwide awareness series coordinated by the Republic of China Head and Neck Cancer Care Association, brought together leading specialists to explain this innovative radiation treatment and its evolving role in cancer care.
Dr. Yang Zhengjie, chairman of the Head and Neck Cancer Care Association, spearheaded the initiative to deepen patient understanding of emerging therapies. His long-standing commitment to supporting working-age cancer patients and advocating for improved post-treatment rehabilitation and immunotherapy access helped shape the event’s focus on practical, patient-centered advancements.
During the session, Dr. Hou Sijen, director of Dalin Tzu Chi Hospital’s Head and Neck Cancer Center, and Dr. Qiu Wenyan from the hospital’s Radiation Oncology Department provided detailed insights into BNCT’s mechanisms and clinical development. They emphasized how this targeted approach minimizes damage to healthy tissues while effectively treating tumors—a critical consideration for head and neck cancers that often impact swallowing, speech, and appearance.
Dalin Tzu Chi Hospital’s head and neck cancer team has long served as a regional benchmark for integrated care in Yunlin, and Chiayi. By aligning with national oral cancer screening policies, the hospital has built a multidisciplinary model combining otolaryngology, hematology-oncology, and radiation oncology services. This comprehensive approach spans diagnosis, treatment, and follow-up, further strengthened by hospital-based resources including nutritional support, social welfare programs, rehabilitation therapies, and patient support groups.
The hospital’s commitment to holistic care was recently validated when it achieved disease care quality certification from the Executive Yuan’s Digital Development Ministry in 2025, reflecting its success in enhancing both treatment outcomes and patients’ quality of life through coordinated, compassionate support throughout the cancer journey.
For head and neck cancer patients in Taiwan’s Yunlin and Chiayi regions, a new hope emerged on April 27, 2026, as Boron Neutron Capture Therapy (BNCT) took center stage at a specialized educational event hosted by Dalin Tzu Chi Hospital. The session, part of a nationwide awareness series coordinated by the Republic of China Head and Neck Cancer Care Association, brought together leading specialists to explain this innovative radiation treatment and its evolving role in cancer care.
Dr. Yang Zhengjie, chairman of the Head and Neck Cancer Care Association, spearheaded the initiative to deepen patient understanding of emerging therapies. His long-standing commitment to supporting working-age cancer patients and advocating for improved post-treatment rehabilitation and immunotherapy access helped shape the event’s focus on practical, patient-centered advancements.
During the session, Dr. Hou Sijen, director of Dalin Tzu Chi Hospital’s Head and Neck Cancer Center, and Dr. Qiu Wenyan from the hospital’s Radiation Oncology Department provided detailed insights into BNCT’s mechanisms and clinical development. They emphasized how this targeted approach minimizes damage to healthy tissues while effectively treating tumors—a critical consideration for head and neck cancers that often impact swallowing, speech, and appearance.
Dalin Tzu Chi Hospital’s head and neck cancer team has long served as a regional benchmark for integrated care in Yunlin and Chiayi. By aligning with national oral cancer screening policies, the hospital has built a multidisciplinary model combining otolaryngology, hematology-oncology, and radiation oncology services. This comprehensive approach spans diagnosis, treatment, and follow-up, further strengthened by hospital-based resources including nutritional support, social welfare programs, rehabilitation therapies, and patient support groups.
The hospital’s commitment to holistic care was recently validated when it achieved disease care quality certification from the Executive Yuan’s Digital Development Ministry in 2025, reflecting its success in enhancing both treatment outcomes and patients’ quality of life through coordinated, compassionate support throughout the cancer journey.
